Thousands of people at higher risk of developing cancer due to inherited faulty genes will be regularly checked and tracked by the NHS thanks to a first-of-its-kind national genetics programme.
A groundbreaking gene editing treatment is being offered to patients with sickle cell disease from today.
Maidenhead, Berkshire£40,192 - £44,012 per annum plus an annual retention bonus of £3,000 subject to eligibility
Rochdale, Greater Manchesterup to £149,041
Maidenhead, Berkshire£40,192 - £44,012 per annum plus an annual retention bonus of £3,000 subject to eligibility
Rochdale, Greater Manchesterup to £149,041